Patents Assigned to TRB CHEMEDICA INTERNATIONAL S.A.
  • Patent number: 9649190
    Abstract: This invention relates to a method for repair of a ligament and/or tendon in a patient comprising applying a patch to said ligament or tendon, wherein the patch is flexible, and bio-compatible and comprises a support layer and a matrix layer.
    Type: Grant
    Filed: March 22, 2013
    Date of Patent: May 16, 2017
    Assignee: TRB Chemedica International S.A.
    Inventor: Burkhard Mathies
  • Patent number: 8957110
    Abstract: The invention concerns topical compositions for the prevention and treatment of ocular pathologies, in particular inflammatory keratites and conjunctivites and dry eye syndrome, containing as active ingredients polyunsaturated fatty acids of the types omega-3 and omega-6, and specifically EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid) and GLA (?-linolenic acid), mixed with vitamin E acetate and formulated in a stable composition in hydrogel, i.e. in dispersed form in an aqueous vehicle containing one or more gelling polymers. The proposed compositions are particularly indicated for use as artificial tears.
    Type: Grant
    Filed: March 18, 2010
    Date of Patent: February 17, 2015
    Assignee: TRB Chemedica International S.A.
    Inventors: Danilo Aleo, Stefano Barabino, Sergio Mangiafico, Maurizio Rolando, Maria Grazia Antonietta Saita
  • Publication number: 20150045887
    Abstract: This invention relates to a method for repair of a ligament and/or tendon in a patient comprising applying a patch to said ligament or tendon, wherein the patch is flexible, and bio-compatible and comprises a support layer and a matrix layer.
    Type: Application
    Filed: March 22, 2013
    Publication date: February 12, 2015
    Applicant: TRB Chemedica International S.A.
    Inventor: Burkhard Mathies
  • Publication number: 20120010280
    Abstract: The invention concerns topical compositions for the prevention and treatment of ocular pathologies, in particular inflammatory keratites and conjunctivites and dry eye syndrome, containing as active ingredients polyunsaturated fatty acids of the types omega-3 and omega-6, and specifically EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid) and GLA (?-linolenic acid), mixed with vitamin E acetate and formulated in a stable composition in hydrogel, i.e. in dispersed form in an aqueous vehicle containing one or more gelling polymers. The proposed compositions are particularly indicated for use as artificial tears.
    Type: Application
    Filed: March 18, 2010
    Publication date: January 12, 2012
    Applicant: TRB CHEMEDICA INTERNATIONAL S.A.
    Inventors: Danilo Aleo, Stefano Barabino, Sergio Mangiafico, Maurizio Rolando, Maria Grazia Antonietta Saita